[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results

AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results

AMPH : 20.42 (+0.54%)
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026

AMPH : 20.42 (+0.54%)
Amphastar: Q2 Earnings Snapshot

Amphastar: Q2 Earnings Snapshot

AMPH : 20.42 (+0.54%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

RANCHO CUCAMONGA, Calif. , Aug. 6, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing,...

AMPH : 20.42 (+0.54%)
Amphastar's Earnings Call Will Reveal Whether the Estimate Collapse Was Justified

Barchart Research What to Expect from AMPH Earnings AMPH Generated August 5, 2026 Current Price $20.24 EPS Estimate $$0.51 Consensus Rating Hold Average Move 11.64% Amphastar's Earnings Call Will Reveal...

AMPH : 20.42 (+0.54%)
What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings

What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings

AMPH : 20.42 (+0.54%)
1 Value Stock to Own for Decades and 2 Facing Challenges

1 Value Stock to Own for Decades and 2 Facing Challenges

EXLS : 34.90 (-0.48%)
AMPH : 20.42 (+0.54%)
AMCX : 11.79 (-0.51%)
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

RANCHO CUCAMONGA, Calif. , July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its second quarter of 2026 ended...

AMPH : 20.42 (+0.54%)
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds

1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds

LSCC : 126.12 (-1.71%)
RELY : 23.61 (+2.03%)
AMPH : 20.42 (+0.54%)
3 Reasons AMPH is Risky and 1 Stock to Buy Instead

3 Reasons AMPH is Risky and 1 Stock to Buy Instead

AMPH : 20.42 (+0.54%)

Barchart Exclusives

This Mag 7 Dividend Stock Is Trading Near 2026 Highs. Why It's Still a Buy.
Microsoft's dividend yield is the highest among the Magnificent 7 companies. Reasonable valuations and strong momentum in AI monetization make MSFT stock a buy despite the sharp rally from its 2026 lows. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.